Core Insights - Chutian Technology is transforming from manufacturing to intelligent manufacturing in the pharmaceutical equipment sector, showcasing its capabilities at the 2025 headquarters factory open day event attended by over 130 pharmaceutical leaders from nearly 30 countries [1] Group 1: Company Overview - Chutian Technology focuses on pharmaceutical equipment and has over ten subsidiaries, including Romaco Holding GmbH and Chutian Microsphere Biotechnology, enabling it to provide comprehensive solutions from laboratory research to commercial production [2] - The company has developed a "smart pharmaceutical factory" ecosystem, emphasizing the importance of key consumables in the innovative drug development process [2][3] Group 2: Product and Technology - Chutian Technology's products include high-tech disposable bioreactor bags for cell culture, which utilize a proprietary 11-layer biocomposite membrane, offering superior physical properties compared to imported alternatives [2] - The company specializes in chromatography media technology, with products certified by the US FDA, supporting the purification of biopharmaceuticals [3] Group 3: Industry Trends - The Chinese regulatory environment is evolving, with new guidelines promoting high-quality development in sterile drug production, driving demand for modular and flexible pharmaceutical equipment [3] - The trend towards small-batch production of diverse drugs is pushing the industry towards more intelligent and higher-specification equipment [3] Group 4: Global Strategy - Chutian Technology aims to become a global leader in pharmaceutical equipment by leveraging its acquisition of Romaco to enhance its international presence [6] - The company has exported products to over 40 countries and regions, with new domestic export orders exceeding 1.2 billion yuan in 2024, marking a significant entry into high-end markets [6] Group 5: Operational Excellence - The company employs digital technologies such as SCADA, MES, and digital twin technology to enhance product traceability and real-time monitoring throughout the production process [4] - Chutian Technology has established a dual-headquarters model, with its headquarters in Changsha focusing on basic research and Romaco in Germany serving the European and American markets, creating a synergistic operational framework [7] Group 6: Future Goals - The company aims to become a leading global pharmaceutical equipment group by 2030, enhancing its international competitiveness and brand influence in the pharmaceutical sector [7]

Core Viewpoint - The company is actively expanding its international market presence and has established localized sales and service networks in over ten key countries and regions, aiming to enhance its global competitiveness and brand influence in the pharmaceutical equipment sector [1][4]. Group 1: International Market Expansion - The company has strategically divided its global operations into five regional departments to strengthen its international sales and service capabilities [1]. - In 2024, the company expects to achieve over 1.2 billion in new export orders, with products entering high-end markets such as Europe [1][4]. - Major international pharmaceutical companies have initiated supplier audits for the company, indicating potential future collaborations [1]. Group 2: Order Delivery and Revenue Recognition - The manufacturing cycle for main products typically ranges from 3 to 9 months, with revenue recognition based on specific criteria for domestic and international orders [2]. - The impact of U.S. tariffs on the company's sales and supply chain is minimal, as exports to the U.S. constitute a small portion of overall revenue [2]. Group 3: Development in Specific Fields - The company has established a joint venture in the peptide synthesis equipment sector, with the subsidiary achieving sales and reporting total assets of approximately 15.61 million and a net loss of about 2.22 million for 2024 [3]. - The company is pioneering the development of smart pharmaceutical factories, focusing on integrating artificial intelligence into its production processes to enhance efficiency and user value [3].